Baiyang Pharmaceutical announced that the 12th meeting of the fourth board of directors of the company deliberated and passed the relevant bill to change the company name from “Qingdao Baiyang Pharmaceutical Co., Ltd.” to “Baiyang Pharmaceutical Group Co., Ltd.”, the stock abbreviation from “Baiyang Pharmaceutical” to “Baiyang Pharmaceutical”, the stock code 301015 remains unchanged, and the abbreviation and code for convertible bonds remain unchanged. At the same time, it is proposed to adjust the scope of business, add content such as drug production, etc., and revise the relevant provisions of the “Articles of Association” accordingly. This change has been reviewed by the Shenzhen Stock Exchange without objection and has been pre-examined by the name of the market supervisory authority. It still needs to be submitted to the shareholders' meeting for review and registration of industrial and commercial changes.

Baiyang Pharmaceutical announced that the 12th meeting of the fourth board of directors of the company deliberated and passed the relevant bill to change the company name from “Qingdao Baiyang Pharmaceutical Co., Ltd.” to “Baiyang Pharmaceutical Group Co., Ltd.”, the stock abbreviation from “Baiyang Pharmaceutical” to “Baiyang Pharmaceutical”, the stock code 301015 remains unchanged, and the abbreviation and code for convertible bonds remain unchanged. At the same time, it is proposed to adjust the scope of business, add content such as drug production, etc., and revise the relevant provisions of the “Articles of Association” accordingly. This change has been reviewed by the Shenzhen Stock Exchange without objection and has been pre-examined by the name of the market supervisory authority. It still needs to be submitted to the shareholders' meeting for review and registration of industrial and commercial changes.